Practical LawConferences

Brian was the first non-Italian General Counsel for Sorin Group, an Italian listed corporation, and largest European company in its medical devices sector. Sorin Group closed in October 2015 a cross border merger with Cyberonics Inc., a US NASDAQ-listed company and world leader in the treatment of epilepsy, which resulted in the merged company being listed on both the London Stock Exchange and NASDAQ. The deal was the most complex cross border of the year, involving two simultaneous de-listings, and two simultaneous listings on new exchanges of the combined company.

Brian is responsible for all business ethics, compliance and legal matters in this multinational medical device group as well as mergers & acquisitions. Brian combines these responsibilities with a leadership role in business model innovation as well as being responsible for the Group’s extensive intellectual property portfolio. Brian has been recognized for his role leading the Group’s multiple-award-winning Business Ethics and Global Compliance Program.

Brian was previously a Partner Oppenheimer, Wolff & Donnelly LLP, and is the author of ‘Biotechnology Regulation and Practice’ (Palladian, 2001). He obtained his LLB, LLM and post-graduate diploma in Competition Law from the University of London.